Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

FDA holds back Alvotech’s Humira biosimilar over manufacturing issues
BioPharma Dive
Tue, 09/6/22 - 04:57 pm
Tags:
Alvotech, AbbVie, Humira, biosimilars, FDA, drug manufacturing
Kymera’s pain could be Priovant’s gain
EP Vantage
Tue, 08/30/22 - 11:41 am
Tags:
Pfizer, hidradenitis suppurativa, Kymera, Priovant, AbbVie
AbbVie fends off patent claim in unusual whistleblower case
Fierce Pharma
Fri, 08/26/22 - 12:18 pm
Tags:
AbbVie, whistleblower lawsuits, whistleblowers, Allergan, Adamas, Alzheimer's disease
AbbVie, J&J's Imbruvica wins first pediatric nod, this one for chronic graft-versus-host disease
Fierce Pharma
Thu, 08/25/22 - 11:04 am
Tags:
JNJ, AbbVie, Imbruvica, graft vs host disease, pediatric, FDA
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
Endpoints
Tue, 08/16/22 - 11:59 pm
Tags:
AbbVie, CD47, SEC, clinical trials, I-Mab, Zai Lab
Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial
Fierce Biotech
Wed, 08/10/22 - 10:49 am
Tags:
Innovent, AbbVie, JNJ, monoclonal antibodies, psoriasis, clinical trials
'What’s wrong with having lots of patents?' Federal appeals judge sides with AbbVie in Humira case
Endpoints
Tue, 08/2/22 - 11:22 pm
Tags:
AbbVie, Humira, patents
AbbVie gives Sosei a StaRring role in neurological drug discovery plans, paying $40M and committing $1.2B
Fierce Biotech
Tue, 08/2/22 - 10:48 am
Tags:
AbbVie, Sosei Heptares, neurological disorders, drug discovery
Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts
Fierce Pharma
Mon, 08/1/22 - 10:53 am
Tags:
Eli Lilly, AstraZeneca, JNJ, AbbVie, legislation, drug pricing, Medicare
In last Q2 with Humira market lock, AbbVie leans on best-seller to offset Imbruvica losses
Fierce Pharma
Mon, 08/1/22 - 10:35 am
Tags:
AbbVie, earnings, Humira
FDA reviewing higher dose Hyrimoz biosimilar
Biopharma Reporter
Fri, 07/22/22 - 11:14 am
Tags:
FDA, Sandoz, biosimilars, Hyrimoz, Humira, AbbVie
AbbVie pens Imbruvica supply pact to support pivotal Oncternal trial
Fierce Biotech
Fri, 07/15/22 - 11:04 am
Tags:
AbbVie, Oncternal, clinical trials, mantle cell lymphoma
Teva, AbbVie ink $58M opioid settlement to resolve San Francisco claims
Fierce Pharma
Wed, 07/13/22 - 10:39 am
Tags:
Teva Pharmaceutical, opioids, opioid crisis, San Francisco, legal, AbbVie, Allergan
AbbVie dumps Alector's Alzheimer's immunotherapy after phase 1 review
Fierce Biotech
Fri, 07/8/22 - 10:43 am
Tags:
Alector, AbbVie, Alzheimer's disease, clinical trials, AL003
AbbVie's Tax Structure in Crosshairs of Senate Finance Committee Report
BioSpace
Thu, 07/7/22 - 06:23 pm
Tags:
AbbVie, taxes, Senate
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
Motley Fool
Tue, 07/5/22 - 11:05 am
Tags:
Rinvoq, AbbVie, Europe, ulcerative colitis
Is AbbVie About To Get A New Blockbuster Drug?
Motley Fool
Mon, 06/27/22 - 10:31 am
Tags:
AbbVie, Parkinson's Disease, ABBV-951
AbbVie Redeems Priority Review Voucher for Rinvoq Approval
BioSpace
Thu, 06/23/22 - 07:53 pm
Tags:
AbbVie, Rinvoq, priority review, priority review vouchers, ulcerative colitis
AbbVie files Qulipta for chronic migraine prevention
Pharmaforum
Wed, 06/22/22 - 10:21 am
Tags:
AbbVie, Qulipta, migraines, FDA
More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy
Fierce Pharma
Mon, 06/20/22 - 10:37 am
Tags:
Novartis, Sandoz, AbbVie, Humira, Europe, biosimilars, autoimmune disease, EMA, Hyrimoz

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.